1. P242 Demographics and clinical characteristics of patients with COPD utilizing LAMA/LABA fixed-dose combination therapy: a U.S. database study. (December 2018) Authors: Ding, B; Kallenbach, L; Slipski, L; Wilk, A; O'Brien, D; Guranlioglu, D Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P243 Relative efficacy and safety of inhaled glycopyrronium+formoterol fumarate dihydrate versus other LAMA+LABA fixed-dose combinations in COPD: a systematic review and bayesian network meta-analysis. (December 2018) Authors: Siddiqui, MK; Singh, I; Jenkins, M; Darken, P; Guranlioglu, D Journal: Thorax Issue: Volume 73(2018)Supplement 4 Page Start: A233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗